Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients

By Matsushita Kohei   Toiyama Yuji   Tanaka Koji   Saigusa Susumu   Hiro Junichiro   Uchida Keiichi   Inoue Yasuhiro   Kusunoki Masato  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 518-527

Springer Publishing Company

Access to resources Recommend Favorite

CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer

By      

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 23-30

Science Publishers

Access to resources Recommend Favorite

Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model

By                          

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 975-982

Spandidos Publications

Access to resources Recommend Favorite

High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer

By Zhang Guang-Jun   Zhou Tong   Tian Hong-Peng   Liu Zuo-Liang   Xia Shu-Sen  

Oncology Letters, Vol. 5, Iss. 2, 2013-02 ,pp. : 564-568

Spandidos Publications

Access to resources Recommend Favorite

The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer

By Peng Lirong   Ning Jinying   Meng Ling   Shou Chengchao  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 9, 2004-09 ,pp. : 521-526

Springer Publishing Company

Access to resources Recommend Favorite